Page last updated: 2024-08-21

ethambutol and HIV Coinfection

ethambutol has been researched along with HIV Coinfection in 94 studies

Research

Studies (94)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (14.89)	18.2507
2000's	20 (21.28)	29.6817
2010's	51 (54.26)	24.3611
2020's	9 (9.57)	2.80

Authors

Authors	Studies
Bollela, VR; Della Pasqua, O; Lanchote, VL; Nardotto, GHB; Rocha, A	1
Abdelwahab, MT; Andrieux-Meyer, I; Bekker, A; Chabala, C; Cotton, MF; Davies, G; Denti, P; Hesseling, A; Lee, J; McIlleron, H; Rabie, H; Tikiso, T; Wiesner, L; Zar, HJ	1
Anderson, G; Vinnard, C	1
Chimbetete, T; Choshi, P; Lehloenya, R; Meintjes, G; Pedretti, S; Peter, J; Phillips, E; Porter, M; Smith, R	1
Aboubakari, AS; Bombonne, M; Darré, T; Djiwa, T; Douaguibe, B; Kambote, Y; Sama, BM; Simgban, P; Tchaou, M	1
Béranger, A; Gegia, M; Linh, NN; Mirzayev, F; Mohamed, A; Nahid, P; Radtke, K; Savic, RM; Schumacher, SG; Solans, BP	1
Äbelö, A; Ashton, M; Bienvenu, E; Birgersson, S; Sundell, J	1
Bozeman, L; Burman, WJ; Chaisson, RE; Chang, KC; Chen, M; Cotton, M; Dooley, KE; Dorman, SE; Engle, M; Feng, PJ; Fletcher, CV; Goldberg, SV; Ha, P; Heilig, CM; Johnson, JL; Kurbatova, EV; Lessem, E; Metchock, B; Miro, JM; Nahid, P; Nhung, NV; Pettit, AC; Phillips, PPJ; Podany, AT; Purfield, AE; Robergeau, K; Samaneka, W; Scott, NA; Sizemore, E; Swindells, S; Vernon, A; Weiner, M	1
Xiao, K; Zhong, L	1
Kubo, M; Omonge, E; Otieno, F; Shiruli, B	1
Chirehwa, MT; Denti, P; McIlleron, H; Mthiyane, T; Onyebujoh, P; Rustomjee, R; Smith, P	2
Cross, GB; Hoy, JF; Smibert, OC; Trubiano, JA	1
Buzibye, A; Castelnuovo, B; Corti, N; Fehr, J; Gutteck, U; Henning, L; Kambugu, A; Lamorde, M; Ledergerber, B; Muller, D; Musaazi, J; Sekaggya-Wiltshire, C; von Braun, A	1
Jo, KW; Kim, WS; Lee, SD; Park, S; Shim, TS	1
de Kock, M; Denti, P; Garcia-Prats, AJ; Hesseling, AC; McIlleron, H; Norman, J; Schaaf, HS; Tikiso, T; van der Laan, LE; Wiesner, L; Winckler, J	1
Cadilla, AJ; Guerreiro, H; Vaz, AM; Velasco, F	1
Ameni, G; Medihn, G; Mersha, W; Tamirat, M; Teklu, T; Wondale, B	1
Brás, S; Carvalho, R; Mendes-Bastos, P	1
Adane, K; Dinant, GJ; Spigt, M	1
Agiboth, HKK; Angamuthu, P; Arasan, G; Ayyamperumal, M; Chandrasekaran, P; Chockalingam, C; Gopalan, N; Jayabal, L; Jayanthi, N; Kannabiran, BP; Kesavamurthy, B; Krishnamoorthy, V; Krishnaraja, R; Lakshman, S; Manoharan, T; Menon, PA; Murali, L; Narayanan, R; Palaniappan, AN; Ramachandran, R; Rathinam, P; Rathinam, S; Reddy, D; Santhanakrishnan, RK; Satagopan, K; Sathiyavelu, S; Selvachitiram, M; Sivaramakrishnan, GN; Suresh, C; Susaimuthu, S; Swaminathan, S; Tripathy, SP	1
Addise, D; Admasu, A; Amare, M; Beyene, D; Dagne, B; Mesfin, EA; Tesfaye, A; Tesfaye, E; Tessema, B; Yaregal, Z	1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y	1
Bang, H; Delva, S; Joissaint, G; Koenig, SP; Pape, JW; Peeples, M; Pry, J; Royal, G; Souroutzidis, A; Vilbrun, SC; Walsh, KF; Widmann, P	1
Kabra, SK; Lodha, R; Mukherjee, A	1
Li, QF; Li, YJ; Liao, Y; Luo, J; Wang, DM; Wu, GH; Xu, YH; Zhong, J; Zhu, M	1
Bunte, A; Fätkenheuer, G; Jaspers, N; Jung, N; Lehmann, C; Maria Fünger, S; Mehrkens, D; Plum, G; Reimer, RP; Rybniker, J; Schmidt, M; Suárez, I	1
Bisson, GP; Gumbo, T; Ivaturi, V; Mehta, K; Modongo, C; Pasipanodya, JG; Ravimohan, S; Srivastava, S; Vinnard, C; Weissman, D; Zetola, NM	1
Herieka, E; Seneviratne, K	1
Horsburgh, CR; Kvasnovsky, C; Master, I; O'Donnell, MR; Padayatchi, N; Werner, L	1
Camara, C; Furtado, A; Gerstoft, J; Katzenstein, TL; Lüneborg-Nielsen, M; Sodemann, M; Wejse, C	1
Cox, H; Fielding, K; Finlayson, H; Godfrey-Faussett, P; Hesseling, AC; Hughes, J; Schaaf, HS; Seddon, JA	1
Berhan, A; Berhan, Y; Yizengaw, D	1
Heysell, SK; Reynolds, J	1
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A	1
Chigutsa, E; Gumbo, T; McIlleron, H; Pasipanodya, JG; Sirgel, FA; Smith, PJ; van Helden, PD; Visser, ME	1
Alobu, I; Oshi, DC; Oshi, SN; Ukwaja, KN	1
Eckold, C; Evangelopoulos, D; Gillespie, SH; Honeyborne, I; Lipman, MC; McHugh, TD; Pym, A	1
Acuña-Villaorduña, C; Ayakaka, I; Dryden-Peterson, S; Fennelly, KP; Hosford, J; Jones-López, EC; Nakubulwa, S; Okwera, A; Reilly, N; Worodria, W	1
Davies, G; Dimba, A; Dzinjalamala, FK; Molyneux, EM; Molyneux, ME; van Oosterhout, JJ; Ward, S; Waterhouse, D; Zijlstra, EE	1
Egan, D; Hennig, S; Kellerman, T; McIlleron, H; Naiker, S; Owen, A; Pym, A; Reddy, T; Wiesner, L	1
Albuquerque, J; David, S; Duarte, EL; Gonçalves, G; Lavinha, J; Mateus, AR; Portugal, C; Sancho, L	1
Libershteyn, Y	1
Bekker, A; Donald, PR; Draper, HR; Hesseling, AC; McIlleron, HM; Murray, S; Schaaf, HS; van der Laan, L; Wiesner, L	1
Kabra, SK; Kanhiya, K; Lodha, R; Mukherjee, A; Singla, M; Velpandian, T	1
Inge, LD; Wilson, JW	1
East, JW; Kahlon, SS; Sarria, JC	1
Coelho, E; De Capitani, EM; Joaquim, OA; Nunes, EA; Panunto, AC; Ramos, Mde C	1
Ambroggi, M; Ambrosioni, J; Brezzo, C; Cecchini, D; Corti, M; Perez, M; Poggi, S; Rybko, A	1
Bradford, WZ; Chideya, S; Hopewell, PC; Kenyon, TA; Moeti, TL; Peloquin, CA; Reingold, AL; Tappero, JW; Wells, CD; Winston, CA	1
Chinnaiyan, P; Iliayas, S; Menon, PA; Narayanan, PR; Narendran, G; Padmapriyadarsini, C; Ramachandran, R; Sakthivel, R; Santhanakrishnan, R; Suhadev, M; Swaminathan, S; Venkatesan, P	1
Baseke, J; Boom, WH; Charlebois, E; Chervenak, KA; Havlir, DV; Johnson, DF; Lancioni, C; Mahan, CS; Mayanja-Kizza, H; Mugerwa, RD; Walusimbi, M; Whalen, CC	1
Baquero, F; Buitrago, LA; Burgos Revilla, J; Gómez García, I; Gómez Mampaso, E; Gómez Rodríguez, A; Molina, MR; Sampietro Crespo, A	1
Camara, P; Chevalier, B; Debonne, JM; Fabre, M; Gueye, M; Herve, V; Lefebvre, N; Margery, J; Mbaye, PS; Perrier-Gros-Claude, JD; Sane, M; Simon, F; Soler, C; Thiam, M	1
Azevedo, V; Barnard, M; Coetzee, D; Coetzee, G; Cox, HS; Goemaere, E; McDermid, C; Muller, O; Simpson, J; van Cutsem, G	1
Diop, SA; Nichols, S; Salou, M; Tidjani, O; Wateba, MI; Womitso, K	1
Bonkoungou, V; Carvalho, AC; Comelli, M; Cusato, M; Dembélé, SM; Kouanda, S; Matteelli, A; Nacanabo, R; Regazzi, M; Saleri, N; Villani, P	1
Freedberg, KA; Kumarasamy, N; Losina, E; Mayer, KH; Pho, MT; Ponnuraja, C; Scott, CA; Swaminathan, S; Uhler, LM; Walensky, RP	1
Abdissa, A; Abdissa, K; Abebe, G; Agonafir, M; Apers, L; Colebunders, R; de-Jong, BC	1
Hesseling, AC; Jordaan, A; Marais, BJ; Schaaf, HS; Seddon, JA; Victor, T	1
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B	1
Aarnoutse, RE; Boeree, MJ; Burger, DM; Fillekes, Q; Kibiki, GS; Kisanga, ER; Kisonga, RM; Mleoh, L; Mtabho, CM; Ndaro, A; Semvua, HH; van den Boogaard, J; van der Ven, A	1
Elson, I; Friedland, G; Gandhi, NR; Kreiswirth, BN; Mathema, B; Moll, AP; Moodley, P; Ramathal, M; Rothenberg, R; Shah, NS; Shashkina, E; Sturm, AW; Weissman, D	1
Chandrasekaran, P; Chinnaiyan, P; Elangovan, T; Gopalan, N; Iliayas, S; Menon, PA; Navaneethapandian, PD; Paranji Ramaiyengar, N; Perumal, V; Pho, MT; Ramachandran, R; Santhanakrishnan, RK; Swaminathan, S; Wares, F	1
Lueangniyomkul, A; Mankatitham, W; Manosuthi, S; Manosuthi, W; Nilkamhang, S; Sukasem, C; Sungkanuparph, S; Thongyen, S	1
Bambery, P; Bhatnagar, A; Khullar, M; Singh, S; Sud, A; Wanchu, A	1
Arevalo, J; Campos, PE; Holmes, KK; Hooton, TM; Nolan, CM; Sanchez, J; Suarez, PG; Ticona, E; Zavala, D	1
Maartens, G; Texeira-Swiegelaar, C; Visser, ME	1
Chaisson, RE; Karakousis, PC; Moore, RD	1
Bhagavathy, S; Gurumurthy, P; Hemanth Kumar, AK; Mahilmaran, A; Padmapriyadarsini, C; Paramesh, P; Rajasekaran, S; Ramachandran, G; Ravichandran, N; Sekar, L; Swaminathan, S; Venkatesan, P	1
Ige, OM; Odaibo, GN; Olaleye, OD; Sogaolu, OM	1
Agerton, TB; Bradford, WZ; Hopewell, P; Kenyon, TA; Lockman, S; Moeti, TL; Moffat, HJ; Oyewo, A; Peloquin, CA; Reingold, AL; Talbot, EA; Tappero, JW	1
Hafner, R; Peloquin, CA; Perlman, DC; Rainey, PM; Remmel, RP; Rosenkranz, S; Salomon, N; Segal, Y	1
Bell, DJ; Graham, SM; Hartkoorn, R; Molyneux, EM; Nyirongo, S; Ward, SA	1
De Broucker, T; Martinez-Almoyna, L; Steichen, O	1
Shirasaka, T	1
Gomathy, P; Iliayas, S; Kumar, SR; Mathew, M; Narayanan, PR; Padmapriyadarsini, C; Sukumar, B; Swaminathan, S; Thomas, B; Triveni, C	1
Angarano, G; Carbonara, D; Costa, D	1
Alland, D; Brudney, K; Crawford, JT; Frieden, TR; Fujiwara, PI; Hewlett, D; Kreisworth, BN; Maw, KL; Nivin, B; Sharp, V; Sherman, LF	1
Coker, RJ; Fisher, M; Tomlinson, DR	1
Kuijper, EJ; Prins, JM; Schultsz, C; van Soolingen, D	1
Cameron, DW; Gallicano, K; Garber, G; Oliveras, L; Rachlis, A; Sahai, J; Seguin, I; Swick, L; Tailor, S; Walker, S	1
de La Blanchardiere, A; Decazes, JM; Herrmann, JL; Hocqueloux, L; Lesprit, P; Modai, J; Zagdanski, AM	1
Eladari, D; Klotz, F; Mbaye, PS; Sane, M; Talarmin, F	1
Keiser, P; Nassar, N; Rademacher, S; Skiest, D; Smith, JW	1
Barker, J; Makatini, Z; Millard, J	1
Fonquernie, L; Frottier, J; Kirstetter, M; Le Van, JC; Meynard, JL; Meyohas, MC; Prévot, S	1
Kaube, H; Koeppen, S; Mummel, P	1
Zuger, A	1
Antunes, ML; Binkin, N; Camacho, M; Espinal, MA; Fusheng, Z; George, AG; Kim, SJ; Laserson, K; Martin-Casabona, N; Raviglione, MC; Simelane, P; Smith, I; Suarez, P; Tlali, RE; Weyer, K	1
Lumb, R; Shaw, D	1

Reviews

10 review(s) available for ethambutol and HIV Coinfection

Article	Year
Population pharmacokinetics of ethambutol in African children: a pooled analysis. The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7 Topics: Anti-HIV Agents; Antitubercular Agents; Child; Child, Preschool; Ethambutol; HIV Infections; Humans; Infant, Newborn; Lopinavir; Ritonavir	2022
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 05-03, Volume: 76, Issue:9 Topics: Adolescent; Adult; Antitubercular Agents; Child; Ethambutol; HIV; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis	2023
Pharmacokinetics of First-Line Anti-Tubercular Drugs. Indian journal of pediatrics, 2019, Volume: 86, Issue:5 Topics: Age Factors; Antitubercular Agents; Child; Drug Overdose; Ethambutol; Food; Genotype; HIV Infections; Humans; Isoniazid; Malnutrition; Nutritional Status; Polymorphism, Genetic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis	2019
Severe disseminated tuberculosis in HIV-negative refugees. The Lancet. Infectious diseases, 2019, Volume: 19, Issue:10 Topics: Adolescent; Adult; Antibiotics, Antitubercular; Ethambutol; Fluorine Radioisotopes; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Positron Emission Tomography Computed Tomography; Pyrazinamide; Refugees; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2019
A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection? Ethiopian journal of health sciences, 2013, Volume: 23, Issue:3 Topics: Adolescent; Adult; Africa South of the Sahara; Aged; Aged, 80 and over; Antitubercular Agents; Child; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Understanding pharmacokinetics to improve tuberculosis treatment outcome. Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:6 Topics: Antitubercular Agents; Diabetes Mellitus; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Microbial Sensitivity Tests; Pyrazinamide; Rifamycins; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary	2014
Tuberculous orchiepididymitis during 1978-2003 period: review of 34 cases and role of 16S rRNA amplification. Urology, 2010, Volume: 76, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Combined Modality Therapy; Comorbidity; Epididymitis; Ethambutol; Exudates and Transudates; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Orchitis; Prostatitis; Pyrazinamide; Retrospective Studies; Ribotyping; Rifampin; RNA, Ribosomal, 16S; Scrotum; Spain; Tuberculosis, Male Genital; Tuberculosis, Renal; Urine	2010
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. The Lancet. Infectious diseases, 2004, Volume: 4, Issue:9 Topics: Age Factors; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Clarithromycin; Ethambutol; HIV Infections; HIV-1; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection	2004
[Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients]. Kekkaku : [Tuberculosis], 2007, Volume: 82, Issue:11 Topics: AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Lymphocyte Count; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Rifabutin; Tuberculosis	2007
Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients. Chest, 1998, Volume: 113, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; CD4 Lymphocyte Count; Clarithromycin; Ethambutol; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Pulmonary Alveoli; Rifabutin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	1998

Trials

17 trial(s) available for ethambutol and HIV Coinfection

Article	Year
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. Contemporary clinical trials, 2020, Volume: 90 Topics: Adolescent; Adult; Antitubercular Agents; Directly Observed Therapy; Drug Administration Schedule; Drug Therapy, Combination; Equivalence Trials as Topic; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Moxifloxacin; Rifampin; Tuberculosis, Pulmonary; Young Adult	2020
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial. JAMA internal medicine, 2018, 04-01, Volume: 178, Issue:4 Topics: Adult; Anti-HIV Agents; Antitubercular Agents; CD4 Lymphocyte Count; Directly Observed Therapy; Drug Administration Schedule; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Isoniazid; Male; Middle Aged; Patient Dropouts; Proportional Hazards Models; Rifampin; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viral Load	2018
Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:10 Topics: Adult; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Dietary Supplements; Drug Therapy, Combination; Ethambutol; Female; Guinea-Bissau; HIV Core Protein p24; HIV Infections; HIV-1; HIV-2; Humans; Isoniazid; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Rifampin; RNA, Viral; Tuberculosis, Pulmonary; Vitamin D; Young Adult	2013
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Disinfection; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Sputum; Sterilization; Treatment Outcome; Tuberculosis; Young Adult	2015
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Malawi; Male; Middle Aged; Pyrazinamide; Rifampin; Young Adult	2015
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Adult; Antitubercular Agents; Area Under Curve; CD4 Lymphocyte Count; Coinfection; Ethambutol; Female; Gene Expression; HIV Infections; Humans; Isoniazid; Liver-Specific Organic Anion Transporter 1; Male; Monte Carlo Method; Organic Anion Transporters; Polymorphism, Single Nucleotide; Pyrazinamide; Rifabutin; Rifampin; Sex Factors; Tuberculosis, Pulmonary	2016
Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4 Topics: Anti-Bacterial Agents; Area Under Curve; Coinfection; Drug Dosage Calculations; Ethambutol; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary	2016
Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial. American journal of respiratory and critical care medicine, 2010, Apr-01, Volume: 181, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Pyrazinamide; Rifampin; Tuberculosis; Viral Load	2010
Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count. PloS one, 2010, Feb-22, Volume: 5, Issue:2 Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Ethambutol; Female; Flow Cytometry; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis; Uganda; Viral Load; Young Adult	2010
Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study. Antiviral therapy, 2013, Volume: 18, Issue:1 Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Organophosphonates; Oxazines; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary	2013
Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. PloS one, 2012, Volume: 7, Issue:12 Topics: Adult; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Female; HIV Infections; Humans; Incidence; India; Isoniazid; Male; Middle Aged; Treatment Outcome; Tuberculosis	2012
The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2004, Volume: 8, Issue:2 Topics: Adult; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Pyridoxine; Rifampin; Time Factors; Tuberculosis, Pulmonary	2004
Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Acetylation; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biological Availability; Ethambutol; Feces; Female; HIV Infections; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Phenotype; Pyrazinamide; Rifampin; Tuberculosis	2004
Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report. African journal of medicine and medical sciences, 2004, Volume: 33, Issue:3 Topics: Acne Vulgaris; Adolescent; Adult; Age Distribution; Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Radiography; Rifampin; Tuberculosis, Pulmonary	2004
The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected persons with tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-01, Volume: 41, Issue:11 Topics: Adult; Antitubercular Agents; Area Under Curve; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Half-Life; HIV Infections; Humans; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary	2005
Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Mar-15, Volume: 46, Issue:6 Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antitubercular Agents; Body Composition; Drug Therapy, Combination; Ethambutol; HIV Infections; HIV Seronegativity; Humans; Hypoalbuminemia; India; Isoniazid; Malnutrition; Nutritional Status; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary	2008
[Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)]. Medicina clinica, 1996, Jan-13, Volume: 106, Issue:1 Topics: Adolescent; Adult; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Spain; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1996

Other Studies

67 other study(ies) available for ethambutol and HIV Coinfection

Article	Year
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients. Clinical and translational science, 2022, Volume: 15, Issue:2 Topics: Adult; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis	2022
Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment. Journal of clinical pharmacology, 2022, Volume: 62, Issue:10 Topics: Antitubercular Agents; Drug Monitoring; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; Tuberculosis	2022
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting. The Journal of investigative dermatology, 2022, Volume: 142, Issue:11 Topics: Antitubercular Agents; Ethambutol; HIV Infections; Humans; Interferon-gamma; Isoniazid; Pyrazinamide; Rifampin; Stevens-Johnson Syndrome	2022
The patterns and distribution of female genital tuberculosis among Togolese patients. The Pan African medical journal, 2022, Volume: 43 Topics: Adult; Cross-Sectional Studies; Ethambutol; Female; HIV Infections; Humans; Tuberculosis; Tuberculosis, Female Genital	2022
Population Pharmacokinetics and Pharmacogenetics of Ethambutol in Adult Patients Coinfected with Tuberculosis and HIV. Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Administration, Oral; Adult; Antitubercular Agents; Biological Availability; Body Weight; Coinfection; Cytochrome P-450 CYP1A2; Ethambutol; Female; Genotype; HIV Infections; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Rwanda; Tuberculosis, Pulmonary	2020
Primary breast tuberculosis in an HIV-infected patient. International journal of STD & AIDS, 2020, Volume: 31, Issue:9 Topics: Adult; Antitubercular Agents; Biopsy; Breast; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis	2020
Poncet's disease in human immunodeficiency virus: a case report. BMC research notes, 2017, Jun-12, Volume: 10, Issue:1 Topics: Adult; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Arthritis, Reactive; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2017
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2017
Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy. AIDS research and human retroviruses, 2017, Volume: 33, Issue:12 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin	2017
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study. BMJ open, 2017, 09-18, Volume: 7, Issue:9 Topics: Adult; Anti-Retroviral Agents; Antitubercular Agents; Biomedical Research; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Combinations; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Research Design; Rifampin; Tuberculosis, Pulmonary; Uganda	2017
Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis. Respiratory medicine, 2017, Volume: 131 Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Comorbidity; Cycloserine; Ethambutol; Female; Fluoroquinolones; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prothionamide; Pyrazinamide; Republic of Korea; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2017
Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Anti-HIV Agents; Antitubercular Agents; Child; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ethambutol; Female; HIV; HIV Infections; Humans; Isoniazid; Lopinavir; Male; Models, Statistical; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Ritonavir; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
Capsule endoscopy in the diagnosis of disseminated BMJ case reports, 2017, Nov-21, Volume: 2017 Topics: Abdominal Pain; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Capsule Endoscopy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fever; HIV Infections; Humans; Intestinal Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Treatment Outcome; Vomiting	2017
A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital, southern Ethiopia. BMC research notes, 2017, Dec-04, Volume: 10, Issue:1 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Drug Combinations; Ethambutol; Ethiopia; Female; HIV Infections; Hospitals, General; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Sex Factors; Streptomycin; Survival Analysis; Treatment Outcome; Tuberculosis, Pulmonary	2017
A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient. International journal of STD & AIDS, 2018, Volume: 29, Issue:7 Topics: Abscess; Aged; AIDS-Related Opportunistic Infections; Antipruritics; Antitubercular Agents; Ethambutol; Female; HIV Infections; Humans; Loratadine; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Skin Diseases, Bacterial; Treatment Outcome	2018
Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis. BMC pulmonary medicine, 2018, Feb-20, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aftercare; Anti-Retroviral Agents; Antitubercular Agents; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Lost to Follow-Up; Male; Multivariate Analysis; Patient Discharge; Patient Transfer; Prisoners; Prisons; Pyrazinamide; Retreatment; Retrospective Studies; Rifampin; Risk Factors; Sputum; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Young Adult	2018
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PloS one, 2018, Volume: 13, Issue:6 Topics: Antitubercular Agents; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant	2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9 Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti. The American journal of tropical medicine and hygiene, 2019, Volume: 100, Issue:2 Topics: Adult; Antitubercular Agents; Coinfection; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Haiti; HIV; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China. Chinese medical journal, 2019, Jun-05, Volume: 132, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Antitubercular Agents; China; Clarithromycin; Ethambutol; Female; HIV Infections; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium Complex; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Pulmonary; Young Adult	2019
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Adult; Antitubercular Agents; Biological Availability; Botswana; Coinfection; Ethambutol; Female; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Tuberculosis, Pulmonary	2019
A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual. International journal of STD & AIDS, 2013, Volume: 24, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Ethambutol; Granuloma; HIV Infections; HIV-1; Humans; Immunocompromised Host; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Skin Diseases, Bacterial	2013
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerging infectious diseases, 2013, Volume: 19, Issue:3 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2013
Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:12 Topics: Antitubercular Agents; Child, Preschool; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Ofloxacin; Prospective Studies; Risk Factors; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2013
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:10 Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2014
Investigating gender disparities in the profile and treatment outcomes of tuberculosis in Ebonyi state, Nigeria. Epidemiology and infection, 2015, Volume: 143, Issue:5 Topics: Adult; Antitubercular Agents; Cohort Studies; Coinfection; Ethambutol; Female; Health Status Disparities; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Nigeria; Pyrazinamide; Retrospective Studies; Rifampin; Rural Population; Sex Factors; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary; Urban Population; Young Adult	2015
Effective anti-tuberculosis therapy correlates with plasma small RNA. The European respiratory journal, 2015, Volume: 45, Issue:6 Topics: Adult; Antitubercular Agents; Biomarkers; Coinfection; Ethambutol; Female; Gene Expression Profiling; HIV Infections; Humans; Isoniazid; Male; MicroRNAs; Prospective Studies; Pyrazinamide; Rifampin; RNA; Treatment Outcome; Tuberculosis, Pulmonary	2015
High mortality associated with retreatment of tuberculosis in a clinic in Kampala, Uganda: a retrospective study. The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:1 Topics: Adult; Antitubercular Agents; Coinfection; Ethambutol; Female; Follow-Up Studies; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Proportional Hazards Models; Pyrazinamide; Recurrence; Retreatment; Retrospective Studies; Rifampin; Streptomycin; Survival Rate; Treatment Failure; Treatment Outcome; Tuberculosis; Uganda	2015
Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis. PloS one, 2015, Volume: 10, Issue:11 Topics: Adolescent; Adult; Age Factors; Aged; Antitubercular Agents; Child; Child, Preschool; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genotype; HIV Infections; Host-Pathogen Interactions; Humans; Infant; Infant, Newborn; Isoniazid; Male; Middle Aged; Molecular Epidemiology; Mycobacterium tuberculosis; Phylogeography; Portugal; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2015
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Biotransformation; Body Weight; Clinical Trials as Topic; Cohort Studies; Coinfection; Computer Simulation; Ethambutol; Female; Half-Life; HIV Infections; Humans; Isoniazid; Liver; Male; Middle Aged; Models, Statistical; Rifampin; Tuberculosis, Pulmonary	2016
Ethambutol/Linezolid Toxic Optic Neuropathy. Optometry and vision science : official publication of the American Academy of Optometry, 2016, Volume: 93, Issue:2 Topics: Aged; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Linezolid; Male; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Vision, Low; Visual Acuity; Visual Fields	2016
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:5 Topics: Adolescent; Age Factors; Antitubercular Agents; Child; Child, Preschool; Chromatography, Liquid; Coinfection; Drug Dosage Calculations; Drug Monitoring; Ethambutol; Female; HIV Infections; Humans; India; Infant; Isoniazid; Male; Prospective Studies; Pyrazinamide; Rifampin; Spectrometry, Mass, Electrospray Ionization; Treatment Outcome; Tuberculosis	2016
Update on the treatment of tuberculosis. American family physician, 2008, Aug-15, Volume: 78, Issue:4 Topics: Antitubercular Agents; Comorbidity; Directly Observed Therapy; Disease Progression; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Mass Screening; Mycobacterium tuberculosis; Patient Compliance; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Rifampin; Risk Factors; Tuberculin Test; Tuberculosis	2008
Mycobacterium-avium-intracellulare complex immune reconstitution inflammatory syndrome in HIV/AIDS presenting as osteomyelitis. The AIDS reader, 2008, Volume: 18, Issue:10 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clarithromycin; Ethambutol; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Osteomyelitis; Rifabutin; Viral Load	2008
Mycobacterium tuberculosis and nontuberculous mycobacterial isolates among patients with recent HIV infection in Mozambique. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2008, Volume: 34, Issue:10 Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mozambique; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2008
Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2009, Volume: 13, Issue:2 Topics: Adult; Antitubercular Agents; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Glucose; HIV Infections; Hospital Mortality; Humans; Isoniazid; Leukocyte Count; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Treatment Outcome; Tuberculosis, Meningeal; Young Adult	2009
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Jun-15, Volume: 48, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Botswana; CD4 Lymphocyte Count; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Serum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult	2009
[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)]. Revue de pneumologie clinique, 2010, Volume: 66, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Hospitals, University; Humans; Immunocompromised Host; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Senegal; Streptomycin; Treatment Failure; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2010
Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PloS one, 2010, Nov-15, Volume: 5, Issue:11 Topics: Adolescent; Adult; Antibiotics, Antitubercular; Comorbidity; Cross-Sectional Studies; Epidemics; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Multivariate Analysis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2010
[Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo]. Medecine et maladies infectieuses, 2011, Volume: 41, Issue:3 Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Inpatients; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Sampling Studies; Sputum; Togo; Tuberculosis, Pulmonary; Young Adult	2011
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Burkina Faso; Chromatography, High Pressure Liquid; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Plasma; Pyrazinamide; Rifampin; Tuberculosis	2012
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PloS one, 2012, Volume: 7, Issue:4 Topics: Adult; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Ethambutol; Female; HIV Infections; Humans; Incidence; India; Isoniazid; Male; Models, Economic; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Treatment Outcome; Tuberculosis	2012
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC research notes, 2012, May-10, Volume: 5 Topics: Adolescent; Adult; Antitubercular Agents; Coinfection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethiopia; Female; HIV Infections; Humans; Isoniazid; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Odds Ratio; Prevalence; Rifampin; Risk Assessment; Risk Factors; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2012
The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:7 Topics: Adolescent; AIDS-Related Opportunistic Infections; Antitubercular Agents; Child; Child, Preschool; Coinfection; Epidemics; Ethambutol; Female; HIV Infections; Humans; Infant; Infant, Newborn; Isoniazid; Male; Mycobacterium tuberculosis; Prevalence; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant	2012
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa. PloS one, 2012, Volume: 7, Issue:8 Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant	2012
Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. The Journal of infectious diseases, 2013, Jan-01, Volume: 207, Issue:1 Topics: Adult; Antitubercular Agents; Cluster Analysis; Cross Infection; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; HIV Infections; Hospitals, Rural; Humans; Isoniazid; Male; Mutation; Mycobacterium tuberculosis; Polymorphism, Restriction Fragment Length; Prevalence; Pyrazinamide; Retrospective Studies; Rifampin; Sequence Analysis, DNA; South Africa	2013
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antitubercular Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Drug Interactions; Ethambutol; Female; Genotype; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Organophosphonates; Oxidoreductases, N-Demethylating; Pharmacogenetics; Polymorphism, Single Nucleotide; Pyrazinamide; Reverse Transcriptase Inhibitors; Rifampin; Tenofovir; Tuberculosis; Young Adult	2013
Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients. BMC infectious diseases, 2002, Jul-29, Volume: 2 Topics: Adult; Antibiotics, Antitubercular; Antitubercular Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Citrulline; Drug Administration Schedule; Enzyme Inhibitors; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Mycobacterium; Nitric Oxide; Nitrites; Pyrazinamide; Rifampin; T-Lymphocyte Subsets; Tuberculosis	2002
Multidrug-resistant Mycobacterium tuberculosis in HIV-infected persons, Peru. Emerging infectious diseases, 2003, Volume: 9, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Infections; Humans; Interviews as Topic; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Peru; Prevalence; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant	2003
Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Aug-15, Volume: 41, Issue:4 Topics: Adult; Antitubercular Agents; Botswana; Comorbidity; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Male; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary	2005
Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:2 Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Ethambutol; HIV Infections; Humans; Infant; Malnutrition; Pyrazinamide; Tuberculosis	2006
[Isoniazid induced neuropathy: consider prevention]. Revue des maladies respiratoires, 2006, Volume: 23, Issue:2 Pt 1 Topics: Acetylation; Achilles Tendon; Adult; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Ethambutol; Female; Guinea; Hepatitis B, Chronic; HIV Infections; Humans; Hypesthesia; Inactivation, Metabolic; Isoniazid; Peripheral Nervous System Diseases; Reflex, Abnormal; Rifampin; Tuberculosis, Pulmonary; Vitamin B 6; Vitamin B 6 Deficiency	2006
Drug resistance of Mycobacterium tuberculosis strains isolated from HIV-infected Italian patients: preliminary report from a multicentric study. The Italian Tuberculosis Drug Resistance Study Group. The new microbiologica, 1995, Volume: 18, Issue:1 Topics: Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; HIV Infections; Humans; Isoniazid; Italy; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant	1995
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA, 1996, Oct-16, Volume: 276, Issue:15 Topics: Adolescent; Adult; Aged; Antitubercular Agents; Blotting, Southern; Cause of Death; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Ethambutol; Female; HIV Infections; Humans; Infant; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; New York City; Polymorphism, Restriction Fragment Length; Proportional Hazards Models; Rifampin; Sputum; Streptomycin; Survival Analysis; Tuberculosis, Multidrug-Resistant	1996
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1996
Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:4 Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium bovis; Mycobacterium Infections; Pyrazinamide; Rifampin	1996
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Annals of internal medicine, 1997, Aug-15, Volume: 127, Issue:4 Topics: Adult; Aged; Antitubercular Agents; Case-Control Studies; Diarrhea; Ethambutol; Female; HIV Infections; HIV Seropositivity; Humans; Intestinal Absorption; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin	1997
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)]. Dakar medical, 1995, Volume: 40, Issue:2 Topics: Adult; Anti-Bacterial Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Female; HIV Infections; Humans; Isoniazid; Liver Function Tests; Pyrazinamide; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary	1995
A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. International journal of STD & AIDS, 1999, Volume: 10, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; CD4 Lymphocyte Count; Ciprofloxacin; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Longitudinal Studies; Male; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Time Factors	1999
Reply to Davis and colleagues: Twice weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa. AIDS (London, England), 1999, Dec-24, Volume: 13, Issue:18 Topics: Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethambutol; HIV Infections; Humans; Isoniazid; Pyrazinamide; Rifampin; South Africa; Tuberculosis, Pulmonary	1999
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment]. Presse medicale (Paris, France : 1983), 2000, Feb-05, Volume: 29, Issue:4 Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Antibiotics, Antitubercular; Antitubercular Agents; Biopsy; CD4 Lymphocyte Count; Clarithromycin; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Granuloma; HIV Infections; Humans; Lymphadenitis; Male; Mesentery; Mycobacterium avium; Peritoneal Diseases; Rifabutin; Time Factors; Tomography, X-Ray Computed; Tuberculosis	2000
Ethambutol related headache in HIV infection: sensitisation to normal CSF pressure? A case report. Journal of neurology, neurosurgery, and psychiatry, 2000, Volume: 68, Issue:4 Topics: Ethambutol; Headache; HIV Infections; Humans; Male; Middle Aged	2000
Jaw swelling in an HIV-infected man. AIDS clinical care, 1996, Volume: 8, Issue:11 Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Lymph Nodes; Male; Mycobacterium avium-intracellulare Infection; Rifabutin	1996
Determinants of drug-resistant tuberculosis: analysis of 11 countries. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2001, Volume: 5, Issue:10 Topics: Adolescent; Adult; Africa; Age Factors; Americas; Antibiotics, Antitubercular; Asia; Child; Child Welfare; Child, Preschool; Drug Resistance, Multiple; Ethambutol; Europe; Female; HIV; HIV Infections; Humans; Infant; Infant Welfare; Infant, Newborn; Male; Middle Aged; Multivariate Analysis; Population Surveillance; Prevalence; Rifampin; Tuberculosis, Multidrug-Resistant	2001
Mycobacterium bovis (BCG) vaccination. Progressive disease in a patient asymptomatically infected with the human immunodeficiency virus. The Medical journal of Australia, 1992, Feb-17, Volume: 156, Issue:4 Topics: Adult; BCG Vaccine; Ethambutol; HIV Infections; Humans; Isoniazid; Male; Mycobacterium bovis; Rifampin; Tuberculosis	1992
Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991. MMWR. Morbidity and mortality weekly report, 1991, Aug-30, Volume: 40, Issue:34 Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Drug Resistance, Microbial; Ethambutol; Florida; HIV Infections; Humans; Isoniazid; New York City; Rifampin; Tuberculosis, Pulmonary	1991
From the Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991. JAMA, 1991, Sep-18, Volume: 266, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Ethambutol; Florida; HIV Infections; Humans; Isoniazid; Middle Aged; New York City; Rifampin; Tuberculosis, Pulmonary	1991